Last reviewed · How we verify

NCT03109587: ProDP

Pilot Study of Probiotics in Pre-diabetic Adolescents

Completed NA Last updated 21 August 2020
What this trial tests

NA trial testing Vivomixx in Obesity, Childhood in 16 participants. Completed in 31 July 2020.

Timeline
1 June 2018
Primary endpoint
31 December 2019
31 July 2020

Quick facts

Lead sponsorSeattle Children's Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment16
Start date1 June 2018
Primary completion31 December 2019
Estimated completion31 July 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Seattle Children's Hospital

Who can join

Adults 13 to 19, any sex, with Obesity, Childhood. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the feasibility and effect of probiotics on glycemic control in obese adolescents.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A randomized double-blind placebo controlled pilot study of probiotics in adolescents with severe obesity.
    Verma A, Nelson MT, DePaolo WR, Hampe C, et al · · 2021 · cited 16× · PMID 34900780 · DOI 10.1007/s40200-021-00855-7

Verify or expand the search:

Other trials of Vivomixx

Trials testing the same drug.

Other recruiting trials for Obesity, Childhood

Currently open trials in the same condition.

Other Seattle Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03109587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing